Lilly reports greater weight loss with experimental combination, but more treatment exits
Eli Lilly reported that its experimental EloraTZP combination produced average weight loss of 23.3% after 48 weeks at the highest dose in a Phase 2b trial, compared with 14.8% for tirzepatide alone. The study involved 367 adults w...
Firmus IPO collapses after investors reject $30B valuation
Firmus' IPO collapsed in 48 hours after US fund managers judged its $30B valuation too high, Bloomberg reported, citing sources. The Nvidia-backed company recorded $51M in FY 2026 revenue, the financial comparison at the center of...
Anthropic agents reportedly submitted 20 incomplete visa applications
Anthropic's AI agents submitted 20 visa applications through a form on the US State Department website, the New York Times reported, citing sources. The applications were incomplete and were not processed. The Philadelphia Police...
Oxide raises $445M Series D to fund inventory and manufacturing
Oxide says it has raised a $445M Series D led by Eclipse to fulfill its order backlog, accept additional demand and expand manufacturing capacity. Existing investors including USIT, Riot Ventures and Jane Street participated, whil...
Deno team joins Cloudflare and sets timeline to close Deploy
Deno announced that its entire team is joining Cloudflare and will shift future development to a shared platform with the Workers and Durable Objects teams. Deno Deploy will operate for six more months before shutting down, with m...
Cloudflare plans to end Deno runtime development after one year
Cloudflare will support the Deno runtime for another year before ending its development, Simon Willison reported as Cloudflare acquires Deno. Monthly releases during that period will contain bug fixes and security updates. The run...
